BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 32028608)

  • 1. Biological Evaluation of Naproxen-Dehydrodipeptide Conjugates with Self-Hydrogelation Capacity as Dual LOX/COX Inhibitors.
    Moreira R; Jervis PJ; Carvalho A; Ferreira PMT; Martins JA; Valentão P; Andrade PB; Perreira DM
    Pharmaceutics; 2020 Feb; 12(2):. PubMed ID: 32028608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic Dehydrodipeptide-Based Self-Assembled Hydrogels for Theragnostic Applications.
    Carvalho A; Gallo J; Pereira DM; Valentão P; Andrade PB; Hilliou L; Ferreira PMT; Bañobre-López M; Martins JA
    Nanomaterials (Basel); 2019 Apr; 9(4):. PubMed ID: 30987203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dehydrodipeptide Hydrogelators Containing Naproxen N-Capped Tryptophan: Self-Assembly, Hydrogel Characterization, and Evaluation as Potential Drug Nanocarriers.
    Vilaça H; Hortelão AC; Castanheira EM; Queiroz MJ; Hilliou L; Hamley IW; Martins JA; Ferreira PM
    Biomacromolecules; 2015 Nov; 16(11):3562-73. PubMed ID: 26443892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-assembled RGD dehydropeptide hydrogels for drug delivery applications.
    Vilaça H; Castro T; Costa FMG; Melle-Franco M; Hilliou L; Hamley IW; Castanheira EMS; Martins JA; Ferreira PMT
    J Mater Chem B; 2017 Nov; 5(43):8607-8617. PubMed ID: 32264529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the properties and potential biomedical applications of NSAID-capped peptide hydrogels.
    Jervis PJ; Amorim C; Pereira T; Martins JA; Ferreira PMT
    Soft Matter; 2020 Nov; 16(44):10001-10012. PubMed ID: 32789370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An injectable, naproxen-conjugated, supramolecular hydrogel with ultra-low critical gelation concentration-prepared from a known folate receptor ligand.
    Oliveira CBP; Veloso SRS; Castanheira EMS; Figueiredo PR; Carvalho ATP; Hilliou L; Pereira RB; Pereira DM; Martins JA; Ferreira PMT; Jervis PJ
    Soft Matter; 2022 May; 18(20):3955-3966. PubMed ID: 35551321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The conjugation of nonsteroidal anti-inflammatory drugs (NSAID) to small peptides for generating multifunctional supramolecular nanofibers/hydrogels.
    Li J; Kuang Y; Shi J; Gao Y; Zhou J; Xu B
    Beilstein J Org Chem; 2013; 9():908-17. PubMed ID: 23766806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a Model Photo-Caged Dehydropeptide as a Stimuli-Responsive Supramolecular Hydrogel.
    Jervis PJ; Hilliou L; Pereira RB; Pereira DM; Martins JA; Ferreira PMT
    Nanomaterials (Basel); 2021 Mar; 11(3):. PubMed ID: 33799670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The conjugates of forky peptides and nonsteroidal anti-inflammatory drugs (NSAID) self-assemble into supramolecular hydrogels for prostate cancer-specific drug delivery.
    Tao M; He S; Liu J; Li H; Mei L; Wu C; Xu K; Zhong W
    J Mater Chem B; 2019 Jan; 7(3):469-476. PubMed ID: 32254734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supramolecular ultra-short carboxybenzyl-protected dehydropeptide-based hydrogels for drug delivery.
    Veloso SRS; Jervis PJ; Silva JFG; Hilliou L; Moura C; Pereira DM; Coutinho PJG; Martins JA; Castanheira EMS; Ferreira PMT
    Mater Sci Eng C Mater Biol Appl; 2021 Mar; 122():111869. PubMed ID: 33641890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dehydropeptide Supramolecular Hydrogels and Nanostructures as Potential Peptidomimetic Biomedical Materials.
    Jervis PJ; Amorim C; Pereira T; Martins JA; Ferreira PMT
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33802425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metabolic effects of inhibitors of 5-lipoxygenase and of cyclooxygenase 1 and 2 are an advancement in the efficacy and safety of anti-inflammatory therapy.
    Celotti F; Durand T
    Prostaglandins Other Lipid Mediat; 2003 Jul; 71(3-4):147-62. PubMed ID: 14518558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unveiling the Role of Capping Groups in Naphthalene N-Capped Dehydrodipeptide Hydrogels.
    Vilaça H; Carvalho A; Castro T; Castanheira EMS; Hilliou L; Hamley I; Melle-Franco M; Ferreira PMT; Martins JA
    Gels; 2023 Jun; 9(6):. PubMed ID: 37367135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Novel Cyclooxygenase-1 Selective Inhibitors of Thiadiazole-Based Scaffold as Potent Anti-Inflammatory Agents with Safety Gastric and Cytotoxic Profile.
    Haroun M; Fesatidou M; Petrou A; Tratrat C; Zagaliotis P; Gavalas A; Venugopala KN; Kochkar H; Emeka PM; Younis NS; Elmaghraby DA; Almostafa MM; Chohan MS; Vizirianakis IS; Papadimitriou-Tsantarliotou A; Geronikaki A
    Molecules; 2023 Apr; 28(8):. PubMed ID: 37110650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of spirostanol glycosides and furostanol glycosides from anemarrhenae rhizoma as dual targeted inhibitors of 5-lipoxygenase and Cyclooxygenase-2 by employing a combination of affinity ultrafiltration and HPLC/MS.
    Xie L; Lee DY; Shang Y; Cao X; Wang S; Liao J; Zhang T; Dai R
    Phytomedicine; 2020 Oct; 77():153284. PubMed ID: 32707371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-amino acids boost the selectivity and confer supramolecular hydrogels of a nonsteroidal anti-inflammatory drug (NSAID).
    Li J; Kuang Y; Gao Y; Du X; Shi J; Xu B
    J Am Chem Soc; 2013 Jan; 135(2):542-5. PubMed ID: 23136972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetically-tailored and nature-derived dual COX-2/5-LOX inhibitors: Structural aspects and SAR.
    Meshram MA; Bhise UO; Makhal PN; Kaki VR
    Eur J Med Chem; 2021 Dec; 225():113804. PubMed ID: 34479036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual acting anti-inflammatory drugs.
    Leone S; Ottani A; Bertolini A
    Curr Top Med Chem; 2007; 7(3):265-75. PubMed ID: 17305569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual synergistic inhibition of COX and LOX by potential chemicals from Indian daily spices investigated through detailed computational studies.
    Rudrapal M; Eltayeb WA; Rakshit G; El-Arabey AA; Khan J; Aldosari SM; Alshehri B; Abdalla M
    Sci Rep; 2023 May; 13(1):8656. PubMed ID: 37244921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel di-tertiary-butyl phenylhydrazones as dual cyclooxygenase-2/5-lipoxygenase inhibitors: synthesis, COX/LOX inhibition, molecular modeling, and insights into their cytotoxicities.
    Ghatak S; Vyas A; Misra S; O'Brien P; Zambre A; Fresco VM; Markwald RR; Swamy KV; Afrasiabi Z; Choudhury A; Khetmalas M; Padhye S
    Bioorg Med Chem Lett; 2014 Jan; 24(1):317-24. PubMed ID: 24295787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.